Janssen and Riyadh Pharma sign partnership agreement

Updated 11 February 2015

Janssen and Riyadh Pharma sign partnership agreement

In culmination of the cooperation that followed signing of the memorandum of understanding (MoU) between Janssen and Riyadh Pharma, the Belgian Janssen Company, and the Medical and Cosmetic Products Company (Riyadh Pharma) have signed a partnership agreement in Saudi Arabia for five years.
Janssen was represented at the signing ceremony by Jan Van der Goten, general supervisor of Janssen for GCC countries, and Riyadh Pharma by Dr. Walid Amin Al-Kayali, CEO of the Medical and Cosmetic Products Company.
‏On the sidelines of the ceremony, Dr. Al-Kayali appreciated this agreement, noting that it aims to promote cooperation in the manufacturing and marketing of some pharmaceutical products of the Belgian Janssen Company in the Kingdom’s Riyadh Pharma factory.
"This will be reflected in consolidation of the Saudi-Belgian relations in all fields of science and economy, in addition to transfer and nationalization of pharmaceutical industries technology and support of self-sufficiency of pharmaceutical products, and upgrade the standard of national pharmaceutical industries," he said, confirming that this will serve the interest of the patient in principle, and will contribute toward making available medicine permanently.
According to him, it will also meet objectives related to the health conditions of medicine by avoiding the effects of transport and weather conditions that have negative impact on the product efficiency and vitality.
Van der Goten praised this agreement and expressed his confidence in Riyadh Pharma and its great capacities and experiences in the Kingdom that made it the first choice of Janssen to be partner in the Kingdom.
It is noteworthy that the Life Medical Company and Riyadh Pharma are among the largest pharmaceutical companies and factories in the Kingdom and both have been working on the fulfillment of medical and pharmaceutical needs of all hospitals and patients in the Kingdom through the pharmaceuticals outlets for over 40 years.
In addition, the two companies are committed to supply and security of medicines by manufacturing and import in accordance with scientific standards and international quality standards applicable in this respect. The two companies are keen on nationalization of pharmaceutical industry for the sake of medicine security in the Kingdom. In this context, Life Medical Company adopted a practical concept by adopting the opening of research course of Dr. Al-Kayali on pharmaceutical industries research.
The research constitutes the cornerstone of advanced researches in the field of pharmaceutical industries that will supply the local or international factories with advanced pharmaceutical formulas which, in turn, will contribute to the provision of research solutions and consultations to local factories and public control authorities in the process of production and removal of obstacles that they may face.
In this respect, Janssen Pharmaceutical Company is one of the largest pharmaceutical companies working in the GCC countries. It was established in 1948. Its head office is located in Riyadh and it employs more than 230 employees of 10 different nationalities.
Janssen Company established strong strategic partnerships with some local health care companies, including Life Medical Company and Riyadh Pharma. In addition, the company established long-term alliances with local medical organizations and associations to upgrade awareness of some diseases and upgrade the level of health care in the GCC countries.
‏Janssen Medical Company, an affiliate of Johnson and Johnson Company Group, is concerned with the study and knowledge of the highest needs of medicine for the diseases that spread at the time such as cancers, psychological and neurological diseases, immunity diseases, cardiac diseases and diabetes, and finding the best solutions for their treatment.


A Jordan startup delivers eco-friendly alternative to dry cleaning

Updated 05 December 2019

A Jordan startup delivers eco-friendly alternative to dry cleaning

  • Products used by WashyWash are non-carcinogenic and environmentally neutral
  • Amman-based laundry service aims to relocate to a larger facility in mid-2020

AMMAN: A persistent sinus problem prompted a Jordanian entrepreneur to launch an eco-friendly dry-cleaning service that could help end the widespread use of a dangerous chemical.

“Dry cleaning” is somewhat of a misnomer because it is not really dry. It is true that no water is involved in the process, but the main cleaning agent is perchloroethylene (PERC), a chemical that experts consider likely to cause cancer, as well as brain and nervous system damage.

Kamel Almani, 33, knew little of these dangers when he began suffering from sinus irritation while working as regional sales director at Eon Aligner, a medical equipment startup he co-founded.

The problem would disappear when he went on vacation, so he assumed it was stress related.

However, when Mazen Darwish, a chemical engineer, revealed he wanted to start an eco-laundry and warned about toxic chemicals used in conventional dry cleaning, Almani had an epiphany.

“He began to tell me how PERC affects the respiratory system, and I suddenly realized that it was the suits I wore for work — and which I would get dry cleaned — that were the cause of my sinus problems,” said Almani, co-founder of Amman-based WashyWash.

“That was the eureka moment. We immediately wanted to launch the business.”

WashyWash began operations in early 2018 with five staff, including the three co-founders: Almani, Darwish and Kayed Qunibi. The business now has 19 employees and became cash flow-positive in July this year.

“We’re very happy to achieve that in under two years,” Almani said.

The service uses EcoClean products that are certified as toxin-free, are biodegradable and cause no air, water or soil pollution.

Customers place orders through an app built in-house by the company’s technology team.

WashyWash collects customers’ dirty clothes, and cleans, irons and returns them. Services range from the standard wash-and-fold to specialized dry cleaning for garments and cleaning of carpets, curtains, duvets and leather goods.

“For wet cleaning, we use environmentally friendly detergents that are biodegradable, so the wastewater doesn’t contain any toxic chemicals,” Almani said.

For dry cleaning, WashyWash uses a modified hydrocarbon manufactured by Germany’s Seitz, whose product is non-carcinogenic and environmentally neutral.

A specialized company collects the waste and disposes of it safely.

The company has big ambitions, planning to expand its domestic operations and go international. Its Amman site can process about 1,000 items daily, but WashyWash will relocate to larger premises in mid-2020, which should treble its capacity.

“We’ve built a front-end app, a back-end system and a driver app along with a full facility management system. We plan to franchise that and have received interest from many countries,” Almani said.

“People visiting Amman used our service, loved it, and wanted an opportunity to launch in their countries.”

WashyWash has received financial backing from angel investors and is targeting major European cities initially.

“An eco-friendly, on-demand dry-cleaning app isn’t available worldwide, so good markets might be London, Paris or Frankfurt,” Almani said.

 

• The Middle East Exchange is one of the Mohammed bin Rashid Al-Maktoum Global Initiatives that was launched to reflect the vision of the UAE prime minister and ruler of Dubai in the field of humanitarian
and global development, to explore the possibility of changing the status of the Arab region. The initiative offers the press a series of articles on issues affecting Arab societies.